I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hosoya, Mitsuru
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (24)
OpenAccess-fulltext (19)
Sorted by: Relevance
Sorted by: Year
?
1
Comparative evaluation of clinical glycemic control markers..:
Osonoi, Takeshi
;
Shirabe, Shinichiro
;
Saito, Miyoko
...
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
2
Dapagliflozin Improves Erythropoiesis and Iron Metabolism i..:
Osonoi, Takeshi
;
Shirabe, Shinichiro
;
Saito, Miyoko
...
Diabetes, Metabolic Syndrome and Obesity. 16 (2023) - p. 1799-1808 , 2023
Link:
https://doi.org/10.2147/..
?
3
Efficacy and safety of switching from febuxostat to dotinur..:
Osonoi, Takeshi
;
Saito, Miyoko
;
Hosoya, Mitsuru
...
Frontiers in Endocrinology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
Metabolic Properties of Lowdensity Lipoprotein (LDL) Trigly..:
Hirano, Tsutomu
;
Kodera, Rieko
;
Hirashima, Takeshi
...
Journal of Atherosclerosis and Thrombosis. 29 (2022) 5 - p. 762-774 , 2022
Link:
https://doi.org/10.5551/..
?
5
Dyslipidemia in diabetic kidney disease classified by prote..:
Hirano, Tsutomu
;
Satoh, Noriyuki
;
Kodera, Rieko
...
Journal of Diabetes Investigation. 13 (2021) 4 - p. 657-667 , 2021
Link:
https://doi.org/10.1111/..
?
6
Nano Particle Emission Evaluation of State of the Art Diese..:
Sogawa, Yasunori
;
Hattori, Hisaya
;
Yanagisawa, Nobuhiro
...
SAE Transactions. 116 (2007) - p. 1013-1023 , 2007
Link:
https://www.jstor.org/st..
?
7
The application of diesel oxidation catalysts to heavy duty..:
Hosoya, Mitsuru
;
Shimoda, Masatoshi
Applied Catalysis B: Environmental. 10 (1996) 1-3 - p. 83-97 , 1996
Link:
https://doi.org/10.1016/..
?
8
Dapagliflozin Improves Erythropoiesis and Iron Metabolism i..:
Osonoi, Takeshi
;
Shirabe, Shinichiro
;
Saito, Miyoko
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DMSO.S411504. , 2023
Link:
https://www.dovepress.co..
?
9
Dapagliflozin Improves Erythropoiesis and Iron Metabolism i..:
Osonoi, Takeshi
;
Shirabe, Shinichiro
;
Saito, Miyoko
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290476/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
Comparative evaluation of clinical glycemic control markers..:
Osonoi, Takeshi
;
Shirabe, Shinichiro
;
Saito, Miyoko
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282941/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
Efficacy and safety of switching from febuxostat to dotinur..:
Osonoi, Takeshi
;
Saito, Miyoko
;
Hosoya, Mitsuru
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875127/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
Dyslipidemia in diabetic kidney disease classified by prote..:
Hirano, Tsutomu
;
Satoh, Noriyuki
;
Kodera, Rieko
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017612/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
13
Comparative evaluation of clinical glycemic control markers..:
Takeshi Osonoi
;
Shinichiro Shirabe
;
Miyoko Saito
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1205021/full. , 2023
Link:
https://doi.org/10.3389/..
?
14
Efficacy and safety of switching from febuxostat to dotinur..:
Takeshi Osonoi
;
Miyoko Saito
;
Mitsuru Hosoya
...
https://www.frontiersin.org/articles/10.3389/fendo.2022.1042061/full. , 2023
Link:
https://doi.org/10.3389/..
?
15
Dyslipidemia in diabetic kidney disease classified by prote..:
Tsutomu Hirano
;
Noriyuki Satoh
;
Rieko Kodera
...
https://doi.org/10.1111/jdi.13697. , 2022
Link:
https://doi.org/10.1111/..
1-15
